PRESS RELEASE published on 11/05/2025 at 18:19, 7 months 28 days ago SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 7 months 28 days ago Christian Mias nommé nouveau PDG de SCHOTT Pharma SCHOTT Pharma Nomination Du PDG Changement De Leadership Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 7 months 28 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 7 months 28 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 10 months 22 days ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
BRIEF published on 08/12/2025 at 07:05, 10 months 22 days ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
PRESS RELEASE published on 08/12/2025 at 07:00, 10 months 22 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 10 months 29 days ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 10:00, 10 months 29 days ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 09:58, 10 months 29 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
Published on 07/03/2026 at 23:00, 2 hours 27 minutes ago Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 21:28, 3 hours 59 minutes ago Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 5 hours 57 minutes ago Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 11 hours 57 minutes ago Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation
Published on 07/03/2026 at 19:00, 6 hours 27 minutes ago PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 6 hours 32 minutes ago Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development
Published on 07/03/2026 at 18:14, 7 hours 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/03/2026 at 18:00, 7 hours 27 minutes ago Charwood Energy: W&nergy, a subsidiary of Charwood Energy, is launching a €2 million crowdfunding campaign on Enerfip.
Published on 07/03/2026 at 18:00, 7 hours 27 minutes ago Charwood Energy: W&nergy, filiale de Charwood Energy, lance une levée de fonds participative de 2 M€ sur Enerfip.
Published on 07/03/2026 at 21:49, 3 hours 37 minutes ago Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 3 hours 37 minutes ago Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 6 hours 45 minutes ago Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:36, 6 hours 50 minutes ago Disclosure of transactions in own shares from July 1 to July 3, 2026
